The increasing incidence of chronic kidney disease, the availability of advanced dialysis, machines disposables and replacement fluids, and increasing government initiatives to increase the accessibility of dialysis treatment and growing adoption home hemodialysis are expected to drive market growth in the coming years
The global Hemodialysis and peritoneal dialysis market size is projected to reach USD 105.1 billion by 2026 from USD 76.9 billion in 2021, at a CAGR of 6.4 % during the forecast period.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Some of the prominent players operating in the global hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson, and Company (US), Dialife SA (Switzerland), and Isopure Corp. (US).
The analysis of market developments between 2018 and 2021 revealed that several growth strategies such as research collaborations and partnerships were adopted by market players to strengthen their product portfolios and maintain a competitive position in the hemodialysis and peritoneal dialysis market
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA is one of the largest providers of products and services for patients with renal diseases. It offers products and services across the entire value chain from a single source.
Its Healthcare Products division includes two major segments, namely, Dialysis Products and Non-dialysis Products. It offers hemodialysis and peritoneal dialysis products through the Dialysis Products segment. The company develops and manufactures dialysis products through 44 production sites and markets these products in more than 150 countries. Fresenius Medical Care provides dialysis treatment to around 346,000 patients through its global network of 4,092 dialysis clinics.
Baxter International Inc.
Baxter is one of the global healthcare companies engaged in the development, manufacturing, and marketing of innovative products for the treatment of patients with infectious diseases, trauma, hemophilia, immune disorders, kidney diseases, and cancer. Baxter operates through two segments—Renal and Hospital Products. The company offers a comprehensive portfolio of dialysis products, including products for PD, in-center HD, home HD, as well as additional dialysis services. Baxter manufactures products in over 20 countries and serves patients and clinicians in around 100 countries. The company focuses mainly on organic growth (through new product development) to sustain its leading position in the global hemodialysis and peritoneal dialysis market.
B. Braun Melsungen AG
B. Braun Melsungen AG offers a wide range of dialysis products, including machines, hemofilters, bloodline systems, vascular access products, and dialysate solutions. The company’s key strength is its wide geographic network. It also emphasizes strengthening its product portfolio by increasing its manufacturing and R&D capabilities. B. Braun has manufacturing facilities in Germany, Brazil, China, France, India, Malaysia, Poland, Switzerland, Spain, Hungary, the US, and Vietnam, among other countries. The company distributes more than 5,000 products in over 64 countries through a network of 262 fully consolidated companies and 22 holding companies.
Nikkiso Co., Ltd.
Nikkiso Co., Ltd. manufactures and markets pumps, sampling and chemical feed systems, equipment for electronic components, aerospace composite products, and medical equipment. The Medical Business segment manufactures and markets hemodialysis machines, dialyzers, blood tubing sets, blood glucose controllers, and powder dialysates. The company has a strong geographical presence in Asia, North America, and Europe.
DaVita Inc. is one of the largest providers of healthcare services in the US for patients who are suffering from chronic kidney failure. The company operates its business through two major divisions— DaVita Kidney Care and DaVita Medical Group. Its Kidney Care division comprises the US dialysis & related lab services and ancillary services & strategic initiatives. The company’s subsidiaries include DaVita Rx, LLC (US), DVA Laboratory Services, Inc. (US), Total Renal Laboratories, Inc. (US), and RMS Lifeline, Inc. (US). The company majorly focuses on the expansion of its dialysis services portfolio with an aim to capture a large customer base in the hemodialysis and peritoneal dialysis market.